XRCC1 and ERCC1 variants modify malignant mesothelioma risk: A case-control study

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 708, Issue 1-2, 2011, Pages 11-20

  Betti, M ^a   Ferrante, D ^a   Padoan, M ^a   Guarrera, S ^b   Giordano, M ^a   Aspesi, A ^a   Mirabelli, D ^c   Casadio, C ^a   Ardissone, F ^c   Ruffini, E ^c   Betta, P G ^d   Libener, R ^d   Guaschino, R ^d   Matullo, G ^b,c   Piccolini, E ^e   Magnani, C ^a   Dianzani, I ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b Human Genetics Foundation   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d C Arrigo Children's Hospital   (Italy)

^e Ospedale S Spirito Casale Monferrato   (Italy)

Author keywords

Asbestos; DNA repair genes; Haplotype; Mesothelioma; Single nucleotide polymorphisms (SNPs)

Indexed keywords

ASBESTOS; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; XRCC1 PROTEIN;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CARCINOGENICITY; CASE CONTROL STUDY; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; ITALY; MAJOR CLINICAL STUDY; MALE; MALIGNANT MESOTHELIOMA; ONCOGENE; ONCOGENE APEX; ONCOGENE ERCC1; ONCOGENE ERCC2; ONCOGENE GPX1; ONCOGENE MGMT; ONCOGENE NBS1; ONCOGENE OGG1; ONCOGENE OPN; ONCOGENE PARP; ONCOGENE PCNA; ONCOGENE RAI; ONCOGENE SEP15; ONCOGENE SOD2; ONCOGENE XRCC1; ONCOGENE XRCC3; POLLUTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ASBESTOS; BASE SEQUENCE; CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; ENDONUCLEASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 79952453654     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2011.01.001     Document Type: Article

References (66)

1. Robinson B.W., Lake R.A. Advances in malignant mesothelioma. N. Engl. J. Med. 2005, 353:1591-1603.
2. Jensen C.G., Jensen L.C.W., Rieder C.L., Cole R.W., Ault J.A. Long crocidolite asbestos fibers cause polyploidy by sterically blocking cytokinesis. Carcinogenesis 1996, 17:2013-2021.
3. Kamp D.W., Weitzman S.A. The molecular basis of asbestos induced lung injury. Thorax 1999, 54:638-652.
4. Wang D., Kreutzer D.A., Essigmann J.M. Mutagenicity and repair of oxidative DNA damage: insight from studies using defined lesions. Mutat. Res. 1998, 400:99-115.
5. Yang H., Bocchetta M., Kroczynska B., Elmishad A.G., Chen Y., Liu Z., Bubici C., Mossman B.T., Pass H.I., Testa J.R., Franzoso G., Carbone M. TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-KappaB-dependent pathway, a possible mechanism for asbestos-induced onocogenesis. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:10397-10402.
6. Christensen B.C., Godleski J.J., Marsit C.J., Houseman E.A., Lopez-Fagundo C.Y., Longacker J.L., Bueno R., Sugarbaker D.J., Nelson H.H., Kelsey K.T. Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma. Carcinogenesis 2008, 29:1555-1559.
7. Marinaccio A., Binazzi A., Cauzillo G., Cavone D., Zotti R.D., Ferrante P., Gennaro V., Gorini G., Menegozzo M., Mensi C., Merler E., Mirabelli D., Montanaro F., Musti M., Pannelli F., Romanelli A., Scarselli A., Tumino R. Italian Mesothelioma Register (ReNaM) Working Group, analysis of latency time and its determinants in asbestos related malignant mesothelioma cases of the Italian register. Eur. J. Cancer 2007, 43:2722-2728.
8. Montanaro F., Rosato R., Gangemi M., Roberti S., Ricceri F., Meier E., Gennaro V., Romanelli A., Chellini E., Pascucci C., Musti M., Nicita C., Barbieri P.G., Marinaccio A., Magnani C., Mirabelli D. Survival of pleural malignant mesothelioma in Italy: a population-based study. Int. J. Cancer 2009, 124:201-207.
9. Cugell D.W., Kamp D.W. Asbestos and the pleura: a review. Chest 2004, 125:1103-1117.
10. Ascoli V., Scalzo C.C., Bruno C., Facciolo F., Lopergolo M., Granone P., Nardi F. Familial pleural malignant mesothelioma: clustering in three sisters and one cousin. Cancer Lett. 1998, 130:203-207.
11. Roushdy-Hammady I., Siegel J., Emri S., Testa J.R., Carbone M. Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey. Lancet 2001, 357:444-445.
12. Metintas M., Hillerdal G., Metintas S., Dumortier P. Endemic malignant mesothelioma: exposure is more important than genetic factors. Arch. Environ. Occup. Health 2010, 65:86-93.
13. Ascoli V., Cavone D., Merler E., Barbieri P.G., Romeo L., Nardi F., Musti M. Mesothelioma in blood related subjects: report of 11 clusters among 1954 Italy cases and review of the literature. Am. J. Ind. Med. 2007, 50:357-369.
14. Ugolini D., Neri M., Ceppi M., Cesario A., Dianzani I., Filiberti R., Gemignani F., Landi S., Magnani C., Mutti L., Puntoni R., Bonassi S. Genetic susceptibility to malignant mesothelioma and exposure to asbestos: the influence of the familial factor. Mutat. Res. 2008, 658:162-171.
15. Neri M., Ugolini D., Dianzani I., Gemignani F., Landi S., Cesario A., Magnani C., Mutti L., Puntoni R., Bonassi S. Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases. Mutat. Res. 2008, 659:126-136.
16. Dianzani I., Gibello L., Biava A., Giordano M., Bertolotti M., Betti M., Ferrante D., Guarrera S., Betta G.P., Mirabelli D., Matullo G., Magnani C. Polymorphisms in DNA repair genes as risk factors for asbestos-related malignant mesothelioma in a general population study. Mutat. Res. 2006, 599:124-134.
17. Magnani C., Dalmasso P., Biggeri A., Ivaldi C., Mirabelli D., Terracini B. Increased risk of malignant mesothelioma of the pleura after residential or domestic exposure to asbestos: a case-control study in Casale Monferrato, Italy. Environ. Health Perspect 2001, 109:915-919.
18. Matullo G., Palli D., Peluso M., Guarrera S., Carturan S., Celentano E., Krogh V., Munnia A., Tumino R., Polidoro S., Piazza A., Vineis P. XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects. Carcinogenesis 2001, 22:1437-1445.
19. Matullo G., Guarrera S., Sacerdote C., Polidoro S., Davico L., Gamberini S., Karagas M., Casetta G., Rolle L., Piazza A., Vineis P. Polymorphisms/haplotypes in DNA repair genes and smoking: a bladder cancer case-control study. Cancer Epidemiol. Biomarkers Prev. 2005, 14:2569-2578.
20. Wang L.I., Miller D.P., Sai Y., Liu G., Su L., Wain J.C., Lynch T.J., Christiani D.C. Manganese superoxide dismutase alanine-to-valine polymorphism at codon 16 and lung cancer risk. J. Natl. Cancer Inst. 2001, 93:1818-1821.
21. Hao B., Wang H., Zhou K., Li Y., Chen X., Zhou G., Zhu Y., Miao X., Tan W., Wei Q., Lin D., He F. Identification og genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma. Cancer Res. 2004, 64:4378-4384.
22. Hung J., Brennan P., Canzian F., Szeszenia-Dabrowska N., Zaridze D., Lissowska J., Rudnai P., Fabianova E., Mates D., Foretova L., Janout V., Bencko V., Chabrier A., Borel S., Hall J., Boffetta P. Large-scale investigation of base excision repair genetic polymorphism and lung cancer risk in a multicenter study. J. Natl. Cancer Inst. 2005, 97:567-576.
23. Lee C.H., Lee K.Y., Choe K.H., Hong Y.C., Noh S.I., Eom S.Y., Ko Y.J., Zhang Y.W., Yim D.H., Kang J.W., Kim H., Kim Y.D. Effects of oxidative DNA damage and genetic polymorphism of the glutathione peroxidase 1 (GPX1) and 8-oxoguanine glycosylase 1 (hOGG1) on lung cancer. J. Prev. Med. Public Health 2006, 39:130-134.
24. Moreno V., Gemignani F., Landi S., Gioia-Patricola L., Chabrier A., Bianco I., Gonzàlez S., Guino E., Capellà G., Canzian F. Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer. Clin. Cancer Res. 2006, 12:2101-2108.
25. Thirumaran R.K., Bermejo J.L., Rudnai P., Gurzau E., Koppova K., Goessler W., Vahter M., Leonardi G.S., Clemens F., Fletcher T., Hemminki K., Kumar R. Single nucleotide polymorphisms in DNA repair genes and basal cell carcinoma skin. Carcinogenesis 2006, 27:1676-1681.
26. Apostolou S., Klein J.O., Mitsuuchi Y., Shetler J.N., Poulikakos P.I., Jhanwar S.C., Kruger W.D., Testa J.R. Growth inhibition and induction of apoptosis in mesothelioma cells by selenium and dependence on selenoprotein SEP15 genotype. Oncogene 2004, 24:5032-5040.
27. Pass H.I., Lott D., Lonardo F., Harbut M., Liu Z., Tang N., Carbone M., Webb C., Wali A. Asbestos exposure, pleural mesothelioma, and serum ospeopontin levels. N. Engl. J. Med. 2005, 353:1564-1573.
28. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
29. Shi Y.Y., He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005, 15:97-98.
30. User Bulletin #2: ABI PRISM 7700 Sequence Detection System.
31. Hung J., Brennan P., Canzian F., Szeszenia-Dabrowska N., Zaridze D., Lissowska J., Rudnai P., Fabianova E., Mates D., Foretova L., Janout V., Bencko V., Chabrier A., Borel S., Hall J., Boffetta P. Larga-scale investigation of base excision repair genetic polymorphism and lung cancer risk in a multicenter study. J. Natl. Cancer Inst. 2005, 97:576-1576.
32. Gonzàlez J.R., Armengol L., Solé X., Guinò E., Mercader J.M., Estivill X., Moreno V. SNPassoc: an R package to perform whole genome association studies. Bioinformatics 2007, 23:644-645.
33. Gemignani F., Neri M., Bottari F., Barale R., Canessa P.A., Canzian F., Ceppi M., Spitaleri I., Cipollini M., Ivaldi G.P., Mencoboni M., Scaruffi P., Tonini G.P., Ugolini D., Mutti L., Bonassi S., Landi S. Risk of malignant mesothelioma and polymorphisms in genes involved in the genome stability and xenobiotics metabolism. Mutat. Res. 2009, 671:76-83.
34. Landi S., Gemignani F., Neri M., Barale R., Bonassi S., Bottari F., Canessa P.A., Canzian F., Ceppi M., Filiberti R., Ivaldi G.P., Mencoboni M., Scaruffi P., Tonini G.P., Mutti L., Puntoni R. Polymorphisms of glutathione-S-transferase M1 and manganese superoxide dismutase are associated with the risk of malignant pleural mesothelioma. Int. J. Cancer 2007, 120:2739-2743.
35. D.B. Petitti, Meta-analysis decision analysis and cost effectiveness analysis, Oxford University Press, New York. 107-113.
36. Wacholder S., Chanock S., Gracia-Closas M., El ghormli L., Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J. Natl. Cancer Inst. 2004, 96:434-442.
37. K.J. Rothman, S. Greenland, T.L. Lash, Modern epidemiology, Lippincott Williams & Wilkins.
38. Maule M.M., Magnani C., Dalmasso P., Mirabelli D., Merletti F., Biggeri A. Modeling mesothelioma risk associated with environmental asbestos exposure. Environ. Health Perspect. 2007, 115:1066-1071.
39. Hosmer D.W., Lemeshow S. Applied logistic regression 1989, John Wiley & Sons, New York (NY).
40. Betti M., Neri M., Ferrante D., Landi S., Biava A., Gemignani F., Bertolotti M., Mirabelli D., Padoan M., Ugolini D., Botta M., Bonassi S., Magnani C., Dianzani I. Pooled analysis of NAT2 genotypes as risk factors for asbestos-related malignant mesothelioma. Int. J. Hyg. Environ. Health 2009, 212:322-329.
41. De Ruyck K., Szaumkessel M., De Rudder I., Dehoorne A., Vral A., Claes K., Velghe A., Van Meerbeeck J., Thierens H. Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk. Mutat. Res. 2007, 631:101-110.
42. Sterpone S., Mastellone V., Padua L., Novelli F., Patrono C., Cornetta T., Giammarino D., Donato V., Testa A., Cozzi R. Single-nucleotide polymorphisms in BER and HHR genes, XRCC1 haplotypes and breast cancer risk in Caucasian women. J. Cancer Res. Clin. Oncol. 2010, 136:631-636.
43. Huang Y., Li L., Yu L. XRCC1 Arg399Gln, Arg194Trp and Arg280His polymorphisms in breast cancer risk: a meta-analysis. Mutagenesis 2009, 24:331-339.
44. Jiang Z., Li C., Xu Y., Cai S. A meta-analysis on XRCC1 and XRCC3 polymorphisms and colorectal cancer risk. Int. J. Colorectal Dis. 2010, 25:169-180.
45. Zhang J., Dhakal I.B., Greene G., Lang N.P., Kadlubar F.F. Polymorphisms in hOGG1 and XRCC1 and risk of prostate cancer: effects modified by plasma antioxidants. Urology 2010, 75:779-785.
46. Kalikaki A., Kanaki M., Vassalou H., Souglakos J., Voutsina A., Georgoulias V., Mavroudis D. DNA repair gene polymorphisms predict favourable clinical out come in advanced non-small-cell lung cancer. Clin. Lung Cancer 2009, 10:118-123.
47. Ricceri F., Guarrera S., Sacerdote C., Polidoro S., Allione A., Fontana D., Destefanis P., Tizzani A., Casetta G., Cucchiarale G., Vineis P., Matullo G. ERCC1 haplotypes modify bladder cancer risk: a case-control study. DNA Repair 2010, 9:191-200.
48. Liang J., Jiang T., Yao R., Liu Z., Lv H., Qi W. The combination of ERCC1 and XRCC1 gene polymorphisms better predicts clinical outcome to oxaliplatin-based chemotherapy in metastatic colorectal cancer. Cancer Chemother. Pharmacol. 2010, 66:493-500.
49. Lao T., Gu W., Huang Q. A meta-analysis on XRCC1 R399Q and R194W polymorphisms, smoking and bladder cancer risk. Mutagenesis 2008, 23:523-532.
50. Lunn R.M., Langlois R.G., Hsieh L.L., Thompson C.L., Bell D.A. XRCC1 polymorphisms: effects on aflatoin B1-DNA adducts and glycophorin A variant frequency. Cancer Res. 1999, 59:2557-2561.
51. Duell E.J., Wiencke J.K., Cheng T.J., Varkonyi A., Zuo Z.F., Ashok T.D.S., Mark E.J., Wain J.C., Christiani D.C., Kelsey K.T. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis 2000, 21:965-971.
52. Au W.W., Salama S.A., Sierra-Torres C. Functional characterization of polymorphisms in DNA repair gene using cytogenetic challenge assay. Environ. Health Perspect 2003, 111:1843-1850.
53. Taylor R.M., Thistlethwaite A., Caldecott K.W. Central role for the XRCC1 BRCT 1 domain in mammalian DNA single-strand break repair. Mol. Cell. Biol. 2002, 22:2256-2263.
54. Monaco R., Rosal R., Dolan M.A., Pincus M.R., Brandt-Rauf P.W. Conformational effects of a common codon 399 polymorphism on the BRCT1 domain of the XRCC1 protein. Protein J. 2007, 26:541-546.
55. Hao B., Miao X., Li Y., Zhang X., Sun T., Liang G., Zhao Y., Zhou Y., Wang H., Chen X., Zhang L., Tan W., Wei Q., Lin D., He F. A novel -77T>C polymorphism in DNA repair gene XRCC1 contributes to diminished promoter activity and increate risk of non-small cell lung cancer. Oncogene 2006, 25:3613-3620.
56. Li M., Yin Z., Guan P., Li X., Cui Z., Zhang J., Bai W., He Q., Zhou B. XRCC1 polymorphisms, cooking oil fume and lung cancer in Chinese women non-smokers. Lung Cancer 2008, 2:145-151.
57. Hsieh W.C., Cheng Y.W., Lin C.J., Chou M.C., Chen C.Y., Lee H. Prognostic significance of X ray cross-complementing group 1 T-77C polymorphism in resected non-small cell lung cancer. Jpn. J. Clin. Oncol. 2009, 39:81-85.
58. Corso G., Marrelli D., Pedrazzani C., Machado J.C., Mancini S., Seruca R., Roviello F. Gastric cardiac carcinoma is associated with the promoter -77T>C gene polymorphism of X-ray cross-complementing group 1 (XRCC1). J. Gastrointest. Surg. 2009, 13:2233-2238.
59. Hansen R.D., Sorensen M., Tjonneland A., Overvad K., Wallin H., Raaschou-Nielsen O., Vogel U. A haplotype of polymorphisms in ASE-1, RAI and ERCC1 and the effects of tobacco smoking and alcohol consumption on risk of colorectal cancer: a Danish prospective case-cohort study. BMC Cancer 2008, 8:54-62.
60. Hoeijmakers J.H.J., Weeda G., Troelstra C., van Duin M., Wiegant J., van der Ploeg M., Geurts van Kessel A.H.M., Westerveld A., Bootsma D. (sub) chromosomal localization of the human excision repair genes ERCC-3 and-6, and identification of a gene (ASE-1) overlapping with ERCC-1. Cytogenet. Cell Genet. 1989, 51:1014.
61. Nexo B.A., Vogel U., Olsen A.E.A. A specific haplotype of single nucleotide polymorphisms on chromosome 19q13.2-3 encompassing the gene rai is indicative of post-menopausal breast cancer before age 55. Carcinogenesis 2003, 24:899-904.
62. Rockenbauer E., Bendixen M.H., Bukowy Z.E.A. Association of chromosome 19q13.2-3 haplotypes with basal cell carcinoma: tentative delineation of an involved region using data for single nucleotide polymorphisms in two cohorts. Carcinogenesis 2002, 23:1149-1153.
63. Vogel U., Laros I., Jacobsen N.R., Thomsen B.L., Bak H., Olsen A., Bukowy Z., Wallin H., Overvad K., Tjonneland A., Nexo B.A., Raaschou-Nielsen O. Two regions in chromosome 19q13.2-3 are associated with risk of lung cancer. Mutat. Res. 2004, 546:65-74.
64. Yin J., Rockenbauer E., Hedayati M.E.A. Multiple single nucleotide polymorphisms on human chromosome 19q13.2-3 associate with risk of basal cell carcinoma. Cancer Epidemiol. Biomarkers Prev. 2002, 11:1449-1453.
65. Yin J., Vogel U., Ma Y., Qi R., Wang H. Haplotypes of nine single nucleotide polymorphisms on chromosome 19q13.2-3 associated with susceptibility of lung cancer in a Chinese population. Mutat. Res. 2008, 641:12-18.
66. Christmann M., Tomicic M.T., Boss W.P., Kaina B. Mechanisms of human DNA repair: an update. Toxicology 2003, 193:3-34.